CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Novo Nordisk A/S - share repurchase programme

Neutral
AI Analysis

Summary

Novo Nordisk has repurchased DKK 7.5 billion of B shares, representing 50% completion of its DKK 15 billion share buyback programme as of August 3, 2026.

Importance:2/10
Sentiment:
0.00
share_repurchasecapital_allocationbuyback_programme
Related Companies

Read the original article

Published by GlobeNewswire Pharma on August 4, 2026 1:41 PM

Read Original